SLNO Operating Cash Flow Growth
Soleno Therapeutics Inc · Operating Cash Flow Growth
SLNO Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported218.35%period ending
SLNO TTM Cash from Operations YoY % (-406.58% → 218.35%)
Year-over-year change
High-resolution chart · PNG
SLNO operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 218.3475% | |
| 167.9866% | |
| 49.9815% | |
| -96.7939% | |
| -190.566% | |
| -177.0489% | |
| -116.328% | |
| -93.8397% | |
| -45.3634% | |
| -20.0135% | |
| -5.6353% | |
| 4.9804% | |
| 20.6313% | |
| 25.1674% | |
| 18.9854% | |
| 18.509% | |
| 1.5118% | |
| -10.0936% | |
| -18.5252% | |
| -29.7617% | |
| -39.8305% | |
| -45.1741% | |
| -46.1366% | |
| -57.1357% | |
| -50.5603% | |
| -48.7204% | |
| -50.1551% | |
| -36.212% | |
| -24.9155% | |
| -17.4176% | |
| -7.8031% | |
| 1.4204% | |
| 12.0546% | |
| 26.2856% | |
| 30.1822% | |
| 26.9387% | |
| 6.2316% | |
| -31.0569% | |
| -67.3673% | |
| -107.3583% | |
| -115.6695% | |
| -129.6721% | |
| -132.2426% | |
| -107.6823% | |
| -66.2322% | |
| -406.5828% |